These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2014-005523-27 Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis Estudio prospectivo multicéntric... bad-data
Completed, but no date 2015-004238-85 Ictal brain SPECT in the premotor stage of Parkinson disease SPECT Ictal de perfusión cerebral en el periodo premotor de la enfermedad de Parkinson bad-data
Ongoing 2016-000347-14 Cell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects Proliferación celular en la hipertensión pulmonar: Det... not-yet-due
Exempt 2016-002972-29 Pilot study on the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B... not-yet-due
Not reported Terminated 2016-003451-30 Subjects with subjective cognitive decline: 18F-Florbetaben Positrón Emission Tomography Study. Estudio de sujetos con deterioro cognitivo subjetivo: estudio con Tomografía por Emisión de Positrone... 2019-02-28 due-trials
Reported results 2016-004499-23 Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial. 2018-03-12 due-trials
Ongoing 2018-001698-25 Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis to prevent ACLF development: a multicenter, double-blind, placebo controlled randomized clinical tria... not-yet-due
Ongoing 2020-006023-33 Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial. Eficacia de la simvastatina para r... not-yet-due
Ongoing 2021-001288-26 Safety, tolerance and antiretroviral activity of dasatinib: a pilot clinical trial in patients with recent HIV-1 infection Seguridad, tolerancia y actividad antirretroviral de dasatinib: estudio cl... not-yet-due
Ongoing 2022-000358-26 Safety, tolerability, and efficacy of a dose reduction strategy based on bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV-infected adults. Seguridad, tolerabilidad y ... not-yet-due